Konstantin Konstantinov - Director at Repligen Corp

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Stock Symbol
RGEN on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Konstantin Konstantinov since 7/7/2023

Holdings reported by Konstantin Konstantinov for Repligen Corp

Class Num Shares Value Price $ Report Date Ownership Underlying Class Underlying Amount
Common Stock 1,921 $314 K $163.34 May 16, 2024 Direct
Stock Option (Right to Buy) 1,376 May 16, 2024 Direct Common Stock

Transactions reported by Konstantin Konstantinov for Repligen Corp

Sym Class Transaction % Value $ Price $ Shares Shares After Date Ownership